{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:04:23Z","timestamp":1785855863901,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Although implantable cardioverter defibrillator (ICD) could prevent the sudden death of ventricular tachycardia (VT) in patients with ischemic heart disease, it could not effectively prevent the recurrence of ventricular tachycardia. Several studies have suggested that catheter ablation may effectively decrease the incidence of ICD events, but relevant dates from randomized controlled trials were limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic review and meta-analysis of randomized controlled trials were performed to evaluate the effect of catheter ablation for the prevention of VT in patients with ischemic heart disease. Random-effects model with inverse-variance weighting method was used to pool odds ratios. Egger method was performed to evaluate whether there was public bias in each outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four studies enrolling a total of 605 patients were included in the present meta-analysis. Compared with the control group (ICD\u2009\u00b1\u2009AAD), catheter ablation could significantly reduce the incidence of ICD therapy (OR, 0.49; 95% CI, 0.28\u2009~\u20090.87), ICD shock (OR, 0.50; 95% CI, 0.28\u2009~\u20090.87), VT storm (OR, 0.60; 95% CI, 0.40\u2009~\u20090.90), and cardiovascular-related hospitalization (OR, 0.66; 95% CI, 0.45\u2009~\u20090.9). But there was no significant difference among the risk of all-cause mortality (OR, 0.89; 95% CI, 0.59\u2009~\u20091.34), cardiovascular mortality (OR, 0.76; 95% CI, 0.44\u2009~\u20091.30), and complication (OR, 0.89; 95% CI, 0.30\u2009~\u20092.67).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results showed that catheter ablation combined with ICD could reduce ICD therapy, ICD shock, and VT storm in patients with ischemic heart disease, but there was no improvement in all-cause mortality. Meanwhile, it also provided a basic guidance for the design of larger clinical randomized trials with longer follow-up in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10840-020-00848-1","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T23:02:22Z","timestamp":1615849342000},"page":"435-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"61","author":[{"given":"Guolin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-6552","authenticated-orcid":false,"given":"Tiewei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"848_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jama.295.7.809","volume":"295","author":"Z Goldberger","year":"2006","unstructured":"Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295:809\u201318.","journal-title":"JAMA."},{"key":"848_CR2","doi-asserted-by":"crossref","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009\u201317.","DOI":"10.1056\/NEJMoa071098"},{"key":"848_CR3","doi-asserted-by":"crossref","unstructured":"Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial. Circulation. 2002;105:589\u201394.","DOI":"10.1161\/hc0502.103330"},{"key":"848_CR4","doi-asserted-by":"crossref","unstructured":"Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760\u20135.","DOI":"10.1161\/01.CIR.0000150390.04704.B7"},{"key":"848_CR5","doi-asserted-by":"crossref","unstructured":"Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med. 2007;167:2226\u201332.","DOI":"10.1001\/archinte.167.20.2226"},{"key":"848_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1099-5129(03)00078-3","volume":"5","author":"HCM Kamphuis","year":"2003","unstructured":"Kamphuis HCM, de Leeuw JRJ, Derksen R, Hauer RNW, Winnubst JAM. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. EP Europace. 2003;5:381\u20139.","journal-title":"EP Europace"},{"key":"848_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1067\/mjh.2002.124049","volume":"144","author":"J Irvine","year":"2002","unstructured":"Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian implantable defibrillator study (CIDS). Am Heart J. 2002;144:282\u20139.","journal-title":"Am Heart J"},{"key":"848_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcm.2017.05.004","volume":"27","author":"CJ MacIntyre","year":"2017","unstructured":"MacIntyre CJ, Sapp JL. Treatment of persistent ventricular tachycardia: drugs or ablation? Trends Cardiovasc Med. 2017;27:506\u201313.","journal-title":"Trends Cardiovasc Med"},{"key":"848_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.15420\/aer.2018.55.5","volume":"8","author":"S Back","year":"2019","unstructured":"Back S, Kowey P. Strategies to reduce recurrent shocks due to ventricular arrhythmias in patients with an implanted cardioverter-defibrillator. Arrhythmia Electrophysiol Rev. 2019;8:99\u2013104.","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"848_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/2048872618781358","volume":"7","author":"AA Hendriks","year":"2018","unstructured":"Hendriks AA, Szili-Torok T. Editor\u2019s choice-the treatment of electrical storm: an educational review. Eur Heart J Acute Cardiovasc Care. 2018;7:478\u201383.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"848_CR11","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165\u201371.","DOI":"10.1001\/jama.295.2.165"},{"key":"848_CR12","doi-asserted-by":"crossref","unstructured":"Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552\u20139.","DOI":"10.1016\/j.hrthm.2016.03.004"},{"key":"848_CR13","doi-asserted-by":"crossref","unstructured":"Kontogiannis C, Tampakis K, Georgiopoulos G, Bartoletti S, Papageorgiou C, Anninos H, et al. Electrical storm: current evidence, clinical implications, and future perspectives. Curr Cardiol Rep. 2019;21:96.","DOI":"10.1007\/s11886-019-1190-0"},{"key":"848_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, And TPG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139.","journal-title":"Ann Intern Med"},{"key":"848_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ."},{"key":"848_CR16","doi-asserted-by":"crossref","unstructured":"Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr\u00e9taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31\u201340.","DOI":"10.1016\/S0140-6736(09)61755-4"},{"key":"848_CR17","doi-asserted-by":"crossref","unstructured":"Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled sms (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422.","DOI":"10.1161\/CIRCEP.116.004422"},{"key":"848_CR18","doi-asserted-by":"crossref","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657\u201365.","DOI":"10.1056\/NEJMoa065457"},{"key":"848_CR19","doi-asserted-by":"crossref","unstructured":"Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111\u201321.","DOI":"10.1056\/NEJMoa1513614"},{"key":"848_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4065\/84.3.289","volume":"84","author":"BA Koplan","year":"2009","unstructured":"Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84:289\u201397.","journal-title":"Mayo Clin Proc"},{"key":"848_CR21","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.ihj.2013.12.039","volume":"66","author":"OA Ajijola","year":"2014","unstructured":"Ajijola OA, Tung R, Shivkumar K. Ventricular tachycardia in ischemic heart disease substrates. Indian Heart J. 2014;66:S24\u201334.","journal-title":"Indian Heart J"},{"key":"848_CR22","doi-asserted-by":"crossref","unstructured":"Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126:2146\u201372.","DOI":"10.1161\/CIR.0b013e31825d59fd"},{"key":"848_CR23","doi-asserted-by":"crossref","unstructured":"Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933\u201340.","DOI":"10.1056\/NEJM199612263352601"},{"key":"848_CR24","doi-asserted-by":"crossref","unstructured":"Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877\u201383.","DOI":"10.1056\/NEJMoa013474"},{"key":"848_CR25","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882\u201390.","journal-title":"N Engl J Med"},{"key":"848_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","volume":"141","author":"S Willems","year":"2020","unstructured":"Willems S, Tilz RR, Steven D, Kaab S, Wegscheider K, Geller L, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141:1057\u201367.","journal-title":"Circulation."},{"key":"848_CR27","doi-asserted-by":"crossref","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"848_CR28","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","volume":"12","author":"R Tung","year":"2015","unstructured":"Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm. 2015;12:1997\u20132007.","journal-title":"Heart Rhythm"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-020-00848-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T02:07:15Z","timestamp":1629425235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-020-00848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00848-1","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript has not been submitted or is under consideration elsewhere in any other journal. No data has been fabricated or manipulated. Consent to submit has been received explicitly from all co-authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}